SLNO is no longer actively traded. Data shown reflects verified historical relationships.
2Suppliers
2Customers
3Debt Items
19Related Chains

Soleno Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
THIRD-PARTY-LOGISTICS-DISTRIBUTION-AGENT-3PL THIRD-PARTY-LOGISTICS-DISTRIBUTION-AGENT-3PL 90% The product is distributed through a third-party logistics distribution agent (3PL) that does not take title to the product.
SPECIALTY-PHARMACY SPECIALTY-PHARMACY 85% In the Company's agreement with the 3PL, the Company acts as principal because it retains control of the product. Once the product is delivered to the Company's specialty pharmacy, the specialty phar…

Soleno Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
SPECIALTY-PHARMACY SPECIALTY-PHARMACY 92% The Company currently sells its product primarily to one customer, a specialty pharmacy.
DELAWARE-GENERAL-CORPORATION DELAWARE-GENERAL-CORPORATION 62% and divert our management’s attention from the operation of our business. Moreover, achieving and sustaining compliance with applicable federal and state privacy, security and fraud laws may prove co…

Soleno Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
SLNO-DEBT Debt stack $54.3M 90% Market cache reports total debt of $54.3M.
SLNO-DEBT-12594 Warrants outstanding: 4439000 90% xbrl warrant detail from xbrl 2026-03-31.
SLNO-DEBT-12595 Xbrl Convertible 90% xbrl convertible detail from xbrl 2018-06-30.

Soleno Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Soleno Therapeutics, Inc..

Soleno Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
SLNO-OWNER-JANUS-HENDERSON-GROUP-PLC JANUS HENDERSON GROUP PLC 90% 13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 228 tracked holders.

Soleno Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
VYGR Voyager Therapeutics, Inc. 100.00 2
ETON Eton Pharmaceuticals, Inc. 100.00 2
AARD Aardvark Therapeutics, Inc. 100.00 2
MICC The Magnum Ice Cream Company N.V. 100.00 2
ASND Ascendis Pharma A/S 100.00 2
MPLT MapLight Therapeutics, Inc. 100.00 2
SNYNF Sanofi 100.00 2
LXEO Lexeo Therapeutics, Inc. 100.00 2
RTO Rentokil Initial plc 100.00 2
XENE Xenon Pharmaceuticals Inc. 100.00 2
TKPHF Takeda Pharmaceutical Company Limited 100.00 2
STQN Strategic Acquisitions, Inc. 100.00 2
SPRB Spruce Biosciences, Inc. 50.00 2
MAZE Maze Therapeutics, Inc. 50.00 2
VTYX Ventyx Biosciences Inc 50.00 2
ORANY ORANGE 50.00 2
NBIX Neurocrine Biosciences, Inc. 38.88 1 ['receiving', 'spend']
JHG Janus Henderson Group plc 38.88 1 ['receiving']
KRC Kilroy Realty Corporation 14.78 2